A comprehensive view of Advent International Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Chemicals Industry Market Intelligence Service.
Advent International and Warburg Pincus finalize acquisition of Baxter's BioPharma Solutions business, rebranding it as Simtra BioPharma Solutions; the standalone CDMO will provide end-to-end services for clients in pharmaceutical and biotech industries
Published:
October 02, 2023
by Business Wire
|
Advent International acquires majority share in niche fragrance brands Parfums de Marly and INITIO Parfums Privés; founder Julien Sprecher will remain with group as Executive Chairman, Creative Director and large minority shareholder
Published:
June 22, 2023
by Advent International Corp.
|
Baxter to divest its BioPharma Solutions business to Advent International and Warburg Pincus for US$4.25B; BPS provides sterile contract manufacturing solutions, parenteral delivery systems, customized support services to pharma and biotech industries
Published:
May 08, 2023
by Baxter International Inc.
|
Ask us about our Chemicals Industry market view